RecruitingNCT04018118

Natural History of Hypereosinophilia and Hypereosinophilic Syndromes

Study of Clinical Profiles of Patients Followed for Chronic Hypereosinophilia and/or Hypereosinophilic Syndrome by the Creation of a National Cohort


Sponsor

University Hospital, Lille

Enrollment

600 participants

Start Date

May 6, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

Unexplained chronic hypereosinophilia (HE) and hypereosinophilic syndromes (HES) are heterogeneous regarding the organ involvements (heart, lungs, skin, .. or none), the evolutionary profiles, the response to treatments. Underlying mechanisms are largely unknown and may associate genetic predisposing factors (germinal ? somatic?), environmental factors (alimentation, tobacco use, hormones, infections, ..) The COHESion study aims to study all clinical and biological characteristics of HE/HES patients and their evolutionary profiles, with a focus on genetic factors and the mechanisms supporting transitory or persistant chronic HE/HES (in absence of any well identified extrinsic trigger like drugs, parasitosis, ..)


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Biological sample for people with eosinophilia and hypereosinophilic syndrome. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALBiological sample

Additional blood samples for biobanking


Locations(1)

Hôpital Roger Salengro, CHU

Lille, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04018118


Related Trials